Research

ACTN3 genotype in professional endurance cyclists


Reference:

Lucia, A., Gomez-Gallego, F., Santiago, C., Bandres, F., Earnest, C. P., Rabadan, M., Alonso, J. M., Hoyos, J., Cordova, A., Villa, G. and Foster, C., 2006. ACTN3 genotype in professional endurance cyclists. International Journal of Sports Medicine, 27 (11), pp. 880-884.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.

Official URL:

http://dx.doi.org/10.1055/s-2006-923862

Related URLs:

Abstract

The Z-disk protein alpha-actinin-3 is only expressed in type II muscle fibres, which are responsible for generating forceful contractions at high velocity. Despite the evolutionary conservation of alpha-actinin-3, approximately one in every five Caucasians of European ancestry is totally deficient in this protein, due to homozygosity for a R577X polymorphism in the ACTN3 gene. This, together with the results of recent research on elite athletes, suggests that the "null" XX polymorphism might confer some advantage to endurance performance events. To test this hypothesis, we studied the frequency distribution of R577X genotypes in a group of 50 top-level male professional cyclists (26.9 +/- 0.4 yrs [mean +/- SEM]; V.O (2max): 73.5 +/- 0.8 ml . kg (-1) . min (-1)). Their results were compared with those of a group of 52 Olympic-class male endurance runners (26.8 +/- 0.6 yrs; V.O (2max): 73.3 +/- 0.8 ml . kg (-1) . min (-1)) and 123 healthy, sedentary male controls. All subjects were Caucasian, and of European ancestry. No significant differences (p > 0.05) were found between groups: RR: 28.5 %; RX: 53.6 % and XX: 17.9 % in controls; RR: 28.0 %; RX: 46.0 % and XX: 26.0 % in cyclists; and RR: 25.0 %; RX: 57.7 %; XX: 17.3 % in runners). No differences were found in indices of endurance performance (VO (2peak) or ventilatory thresholds) between athlete carriers of each R577X genotype. In summary, although the alpha-actinin-3 deficient XX genotype may be detrimental for sprint performance in humans, the R577X polymorphism of the ACTN3 gene does not appear to confer an advantage on the ability of male athletes to sustain extreme endurance performance.

Details

Item Type Articles
CreatorsLucia, A., Gomez-Gallego, F., Santiago, C., Bandres, F., Earnest, C. P., Rabadan, M., Alonso, J. M., Hoyos, J., Cordova, A., Villa, G. and Foster, C.
DOI10.1055/s-2006-923862
Related URLs
URLURL Type
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16612741 https://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-923862Free Full-text
DepartmentsFaculty of Humanities & Social Sciences > Health
RefereedYes
StatusPublished
ID Code29966
Additional Information0172-4622 (Print) Journal Article Genetics and Sport

Export

Actions (login required)

View Item